Journal info
|
||
Select Journal
Journals
Bratislava Medical Journal Endocrine Regulations General Physiology and Biophysics Neoplasma 2024 Ahead of print 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 Acta Virologica Studia Psychologica Cardiology Letters Psychológia a patopsych. dieťaťa Kovove Materialy-Metallic Materials Slovenská hudbaWebshop Cart
Your Cart is currently empty.
Info: Your browser does not accept cookies. To put products into your cart and purchase them you need to enable cookies.
Neoplasma Vol.52, p.364-368, 2005 |
||
Title: A pilot study testing the genetic polymorphism of N-acetyltransferase 2 as a risk factor in lung cancer | ||
Author: V., HABALOVA ; J., SALAGOVIC ; I., KALINA ; J., STUBNA ; | ||
Abstract: NAT2 as phase II enzyme is involved in the detoxification/activation of various drugs, environmental substances and carcinogenic
compounds. A genotyping approach has been used to investigate NAT2 genotype with putative relevance in lung
cancer in population of 110 Slovak-Caucasians patients and 167 non-malignant individuals from the same region. Slow
acetylation was not observed to be a significant risk factor of lung cancer development (OR=1.19; 95% CI: 0.71–1.99).
However, one genotype responsible for slow acetylation (NAT2*5B/*6) was observed significantly more frequently in lung
cancer patients with squamous cell carcinoma compared with control subjects (OR=2.24; 95% CI: 1.14–4.34). Stratified
analysis showed an increasing impact of the specific allelic combination NAT2*5B/*6 in non-smokers (OR=6.5; 95% CI:
1.25–15.08). In the case of squamous lung carcinoma an analysis revealed a tendency to adversely affect cancer risk in the
individuals with the mentioned genotype in younger than 60 years (OR=3.14; 95% CI: 0.98–9.72) non-smokers (OR=10.40;
95% CI: 1.35–118.89) and in females (OR=4.25; 1.08–16.25). Additional studies are needed to confirm the results we observed
and to assess the impact of other effects (specific allelic combinations, sex differences and histological subtype of
lung cancer) on NAT2 susceptibility in lung carcinogenesis.
|
||
Keywords: NAT2, lung cancer, susceptibility, and genetic polymorphism | ||
Year: 2005, Volume: 52, Issue: | Page From: 364, Page To: 368 | |
|
download file |
|